Eli Lilly Chairman and Chief Executive Officer John Lechleiter is taking an unexpected leave of absence. Lechleiter is scheduled for surgery for a dilated aorta on Monday and will hand the CEO reins ...

Awareness of the clinical significance of thoracic aortic aneurismal disease has increased in recent years. As diagnostic tools have improved our ability to identify aortic pathology, surgical ...

INDIANAPOLIS (AP) -- Eli Lilly Chairman and CEO John Lechleiter is back to full-time work after taking a leave in May to have surgery for a dilated aorta. The Indianapolis drugmaker says both a ...

INDIANAPOLIS (AP) — Drugmaker Eli Lilly & Co. said Tuesday that President, CEO and Chairman John Lechleiter will have surgery for a dilated aorta on Monday. The company said the condition was ...

Drug maker Eli Lilly and Co said Chief Executive John Lechleiter will undergo a surgery on May 13 to treat a dilated aorta but is expected to recover and return to work by this summer. Chief Financial ...